Email
Password
Remember meForgot password?
    Log in with Twitter
Press Release

Injectable Drug Delivery Devices Market 2019 Global Overview, Demand Analysis, Advanced Share, Growth Values, Emerging Trends, Sales Revenue, Technology Prospects and, Industry Forecast to 2023

Injectable Drug Delivery Devices Market 2019 Global Overview, Demand Analysis, Advanced Share, Growth Values, Emerging Trends, Sales Revenue, Technology Prospects and, Industry Forecast to 2023
"Injectable Drug Delivery Devices Market"
Market Research Future one of the pioneers of the market research industry has published a research study on “Injectable Drug Delivery Devices Market- Global Forecast to 2023”. This Report provides detailed analysis of the top 10 countries with their share analysis, market size analysis, segmentation analysis, and key players’ analysis

Market Overview:

Drug delivery refers to the technologies, systems, and the approaches used for the administration of drugs to patients. Injectable drug delivery is an approach through which the drug is administered by penetrating a needle or a similar device into the human skin. The injectable drug delivery devices can be narrowed down in terms of types, namely needle-free injectors, self-injectors, and auto-injectors. The global Injectable Drug Delivery Devices market is said to witness a projected growth rate of 11.5% during the forecast period according to the study performed by the Market Research Future (MRFR) team.

Demand for these devices has continued to ameliorate in the recent past due to the benefits it offers through its applications. These devices are used for the treatment of various medical conditions. Owing to the increasing number of medical cases, the Injectable Drug Delivery Devices are witnessing a higher percentage of demand. Ongoing advancements in design and technology are enabling the usage of these devices in more complex delivery procedures and requirements. Some of the other factors that are believed to have a link with the market growth are rising incidences of chronic diseases, growing approvals from the FDA, and the increasing adoption of self-injectable devices. The global market is expected to accrue a valuation of USD 31,900 million by 2023.

Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/1211

Competitive Analysis:

The prominent market players in this segment are

  • Antares Pharma
  • AstraZeneca
  • Eli Lilly and Company
  • Inovio Pharmaceuticals
  • Novo Nordisk
  • Pfizer Inc
  • Dickinson and Company
  • Becton
  • Mylan N.V.
  • Novartis AG
  • F.Hoffmann-La Roche AG
  • Eisai Co. Ltd
  • Teva Pharmaceutical Industries Ltd
  • Johnson & Johnson Services Inc
  • Sanofi.

October 2018, a developer and manufacturer of wearable drug delivery devices, Enable Injections raised a staggering $50 million in a Series B round that was led by Sanofi. Enable’s drug delivery platform, enFuse, can be connected to smartphones via Bluetooth.

January 2019, Tyndall National Institute inked a Research and Development collaboration deal with the West Pharmaceutical Services, Inc. Through this move, Tyndall aims to work on the future developments of the drug delivery systems for injectable medicines.

For Exclusive Discount Offers @ https://www.marketresearchfuture.com/check-discount/1211

Market Segmentation:

  • The global Injectable Drug Delivery Devices market is segmented in terms of usage pattern, therapeutic application, devices, distribution channel, site of delivery, and facility of use.
  • By Devices: It includes conventional and self-injection devices. The conventional injection segment holds a majority of the market share over self-injection devices. Additionally, the conventional injection segment is divided into utility, product, and material. Whereas, the self-injectable injection segment includes pen systems and autoinjectors and needle-free injectors.
  • By Therapeutic Application: The market includes hormonal disorders, autoimmune diseases, cancer, and others. The autoimmune diseases segment holds dominance over others globally and is expected to grow impressively in the future as well.
  • By Usage Pattern: The market divides into curative and immunization. The curative segment is expected to grow at a higher speed than the latter during the forecast period.
  • By Site of Delivery: The market includes subcutaneous, intramuscular, and intradermal. The intramuscular segment dominates this segmentation with the highest market share.

 

  • By Distribution Channel: The market includes online platforms and hospital & retail pharmacies. The hospital & retail pharmacies stand as the leader in this market segment while online platforms are expected to grow with the fastest CAGR of 11.4% during the assessment period.
  • By Facility of Use: The market segmentation includes home care settings, hospitals and clinics, and others.

Regional Analysis:

The global regional segmentation of the Injectable Drug Delivery Devices Market includes Europe, Americas, Asia-Pacific, and the Middle East and Africa.

The Americas is the dominant of the lot owing to the rapid acceptance and adoption of technologically advanced healthcare solutions, the rising prevalence of chronic diseases, expanding size of the biotechnological industry, and a well-established healthcare landscape.

With a projected market valuation of USD 13.074.3 million by the end of 2023, Europe stands as the second-biggest regional market. It is primarily driven by increased R&D funding and easy incorporation of technologically advanced healthcare services.

The Asia-Pacific region holds the podium for being projected as the fastest-growing region of the Injectable Drug Delivery Devices market. Finally, the Middle East and Africa region is expected to witness a steady expansion due to the lack of exposure to healthcare services and the lack of awareness.

Access Full Report Details and TOC Exclusively @ https://www.marketresearchfuture.com/reports/injectable-drug-delivery-devices-market-1211

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/injectable-drug-delivery-devices-market-1211



Latest News
Top News